Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals

Antiviral Research

Volumn 99, Issue 1, 2013, Pages 6-11

  Kim, Hee Young ^a   Li, Xiaolan ^b   Jones, Christopher T ^c   Rice, Charles M ^c   Garcia, Jean Michel ^a   Genovesio, Auguste ^b   Hansen, Michael A E ^b   Windisch, Marc P ^a  

^a Institute Pasteur Korea   (South Korea)

^b Image Mining   (South Korea)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

HCV; High throughput Screening assay; Multiplex; Phenotypic

Indexed keywords

2' METHYLCYTIDINE; A 837093; ANTIVIRUS AGENT; GREEN FLUORESCENT PROTEIN; N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE; NONSTRUCTURAL PROTEIN 5B; PROTEINASE INHIBITOR; RED FLUORESCENT PROTEIN; SOFOSBUVIR; TELAPREVIR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIVISION; CELL GROWTH; CYTOPLASM; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; LIFE CYCLE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; RNA REPLICATION;

HEPATITIS C VIRUS;

EID: 84878007520     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.04.020     Document Type: Article

References (29)

1. Bassit, L., Grier, J., Bennett, M., Schinazi, R.F., 2008. Combinations of 20-Cmethylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system. Antivir. Chem. Chemother. 19, 25-31.
2. Chevaliez, S., Pawlotsky, J.M., 2007. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. 59, 1222-1241.
3. Chockalingam, K., Simeon, R.L., Rice, C.M., Chen, Z., 2010. A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. Proc. Natl. Acad. Sci. USA 107, 3764-3769.
4. Gastaminza, P., Whitten-Bauer, C., Chisari, F.V., 2010. Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc. Natl. Acad. Sci. USA 107, 291-296.
5. Gentzsch, J., Hinkelmann, B., Kaderali, L., Irschik, H., Jansen, R., Sasse, F., Frank, R., Pietschmann, T., 2011. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity. Antiviral Res. 89, 136-148.
6. Ghany, M.G., Nelson, D.R., Strader, D.B., Thomas, D.L., Seeff, L.B., American Association for Study of Liver, D., 2011. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54, 1433-1444.
7. Hayashi, N., Takehara, T., 2006. Antiviral therapy for chronic hepatitis C: past, present, and future. J. Gastroenterol. 41, 17-27.
8. Jones, C.T., Catanese, M.T., Law, L.M., Khetani, S.R., Syder, A.J., Ploss, A., Oh, T.S., Schoggins, J.W., MacDonald, M.R., Bhatia, S.N., Rice, C.M., 2010. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat. Biotechnol. 28, 167-171.
9. Lemm, J.A., O'Boyle 2nd, D., Liu, M., Nower, P.T., Colonno, R., Deshpande, M.S., Snyder, L.B., Martin, S.W., St Laurent, D.R., Serrano-Wu, M.H., Romine, J.L., Meanwell, N.A., Gao, M., 2010. Identification of hepatitis C virus NS5A inhibitors. J. Virol. 84, 482-491.
10. Li, Y.P., Ramirez, S., Jensen, S.B., Purcell, R.H., Gottwein, J.M., Bukh, J., 2012. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc. Natl. Acad. Sci. USA 109, 19757-19762.
11. Lin, K., Perni, R.B., Kwong, A.D., Lin, C., 2006. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells. Antimicrob. Agents Chemother. 50, 1813-1822.
12. Lindenbach, B.D., Evans, M.J., Syder, A.J., Wolk, B., Tellinghuisen, T.L., Liu, C.C., Maruyama, T., Hynes, R.O., Burton, D.R., McKeating, J.A., Rice, C.M., 2005. Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
13. Lindenbach, B.D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A.J., McKeating, J.A., Lanford, R.E., Feinstone, S.M., Major, M.E., Leroux-Roels, G., Rice, C.M., 2006. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Nat. Acad. Sci. USA 103, 3805-3809.
14. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., Bartenschlager, R., 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
15. Loo, Y.M., Owen, D.M., Li, K., Erickson, A.K., Johnson, C.L., Fish, P.M., Carney, D.S., Wang, T., Ishida, H., Yoneyama, M., Fujita, T., Saito, T., Lee, W.M., Hagedorn, C.H., Lau, D.T., Weinman, S.A., Lemon, S.M., Gale Jr., M., 2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Nat. Acad. Sci. USA 103, 6001-6006.
16. Lu, L., Dekhtyar, T., Masse, S., Pithawalla, R., Krishnan, P., He, W., Ng, T., Koev, G., Stewart, K., Larson, D., Bosse, T., Wagner, R., Pilot-Matias, T., Mo, H., Molla, A., 2007. Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro. Antiviral Res. 76, 93-97.
17. Manns, M.P., Wedemeyer, H., Cornberg, M., 2006. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55, 1350-1359.
18. Mondal, R., Koev, G., Pilot-Matias, T., He, Y., Ng, T., Kati, W., Molla, A., 2009. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well. Antiviral Res. 82, 82-88.
19. Moradpour, D., Evans, M.J., Gosert, R., Yuan, Z., Blum, H.E., Goff, S.P., Lindenbach, B.D., Rice, C.M., 2004. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78, 7400-7409.
20. Murakami, E., Tolstykh, T., Bao, H., Niu, C., Steuer, H.M., Bao, D., Chang, W., Espiritu, C., Bansal, S., Lam, A.M., Otto, M.J., Sofia, M.J., Furman, P.A., 2010. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977. J. Biol. Chem 285, 34337-34347.
21. Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M., Cosset, F.L., Bartenschlager, R., 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Nat. Acad. Sci. USA 103, 7408-7413.
22. Shepherd, J., Jones, J., Hartwell, D., Davidson, P., Price, A., Waugh, N., 2007. Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. Health Technol. Assess. 11, 1-205, iii.
23. Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D.G., Okamoto, H., Pawlotsky, J.M., Penin, F., Sablon, E., Shin, I.T., Stuyver, L.J., Thiel, H.J., Viazov, S., Weiner, A.J., Widell, A., 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962-973.
24. Sofia, M.J., Bao, D., Chang, W., Du, J., Nagarathnam, D., Rachakonda, S., Reddy, P.G., Ross, B.S., Wang, P., Zhang, H.R., Bansal, S., Espiritu, C., Keilman, M., Lam, A.M., Steuer, H.M., Niu, C., Otto, M.J., Furman, P.A., 2010. Discovery of a beta-d-20- deoxy-20-alpha-fluoro-20-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. J. Med. Chem. 53, 7202-7218.
25. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H.G., Mizokami, M., Bartenschlager, R., Liang, T.J., 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796.
26. WHO, 2012. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/ index4.html.
27. Wichroski, M.J., Fang, J., Eggers, B.J., Rose, R.E., Mazzucco, C.E., Pokornowski, K.A., Baldick, C.J., Anthony, M.N., Dowling, C.J., Barber, L.E., Leet, J.E., Beno, B.R., Gerritz, S.W., Agler, M.L., Cockett, M.I., Tenney, D.J., 2012. High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus. PLoS ONE 7, e42609.
28. Yi, M., Villanueva, R.A., Thomas, D.L., Wakita, T., Lemon, S.M., 2006. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl. Acad. Sci. USA 103, 2310-2315.
29. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F., Uprichard, S.L., Wakita, T., Chisari, F.V., 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102, 9294-9299.